In Vivo Biomarkers for Limbal Stem Cell Deficiency Staging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing and staging limbal stem cell deficiency (LSCD) are inadequate, as they rely heavily on clinical presentation and impression cytology, which are not sensitive or accurate enough to assess the severity of the condition effectively.
Innovation Solution
A comprehensive diagnostic and staging system utilizing in vivo parameters such as central corneal basal cell density, corneal epithelial thickness, and total corneal nerve fiber length, combined with clinical scores, to objectively assess and stage LSCD, using slit-lamp biomicroscopy, in vivo laser scanning confocal microscopy, and anterior segment optical coherence tomography.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If clinical presentation and impression cytology are used for diagnosis, then the diagnostic process is simple and quick, but the sensitivity and accuracy for detecting LSCD severity are insufficient
Solution Approach 1:
The patent combines multiple diagnostic modalities (slit-lamp biomicroscopy, in vivo laser scanning confocal microscopy, and anterior segment optical coherence tomography) into a comprehensive diagnostic system. This integration allows simultaneous evaluation of clinical signs, corneal nerve fiber parameters, and epithelial thickness, thereby improving diagnostic accuracy without requiring separate complex procedures for each parameter.
Solution Approach 2:
The diagnostic system is designed to perform multiple functions through a unified approach: it can detect the presence of LSCD, stage the severity, and identify specific structural parameters (nerve fiber length, epithelial thickness, basal cell density) all within a single comprehensive evaluation framework, making the system universally applicable for various diagnostic needs.
2Measurement precision
If multiple in vivo parameters are measured to improve diagnostic accuracy, then the detection of disease severity improves, but the examination time and procedure complexity increase
Solution Approach 1:
The patent merges the measurement of multiple parameters (corneal nerve fiber length, corneal nerve fiber density, epithelial thickness, basal cell density) into a single integrated diagnostic workflow using combined imaging modalities. This allows concurrent acquisition of all necessary data points without requiring sequential examinations, thereby reducing total examination time while maintaining comprehensive severity assessment.
Data Source
AI summary
The disclosure provides a comprehensive limbal stem cell deficiency diagnostic and staging system that combines observations of physiological parameters such as clinical presentation, central cornea basal cell density, central corneal epithelial thickness, and total corneal nerve fiber length. It has been discovered that the methodology disclosed herein can both accurately and objectively diagnose limbal stem cell deficiency as well as stage its severity.